학술논문
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission
Document Type
Article
Author
Source
In: Journal of Gastrointestinal and Liver Diseases . (Journal of Gastrointestinal and Liver Diseases, December 2023, 32(4):452-459)
Subject
Language
English
ISSN
18418724